More Than 80 Companies Currently Claim To Offer Manufacturing Related Services, At Different Scales Of Operations, For A Variety Of Oligonucleotide-based Products, Claims Roots Analysis

>

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations, for a variety of oligonucleotide-based products, claims Roots Analysis

 

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.

 

To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

 

The USD 5.8 billion (by 2030) financial opportunity within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments:

  • Type of manufacturing 
  • Custom manufacturing
  • Large-scale manufacturing

 

  • Type of Oligonucleotides manufactured
  • Antisense Oligonucleotides
  • miRNAs
  • shRNAs
  • siRNAs
  • Other Oligonucleotides

 

  • Scale of operation
  • Clinical
  • Commercial

 

  • Purpose of production
  • In-house
  • Outsourced

 

  • Target therapeutic area
  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Genetic Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Neuromuscular Disorders
  • Oncological Disorders
  • Ophthalmic Disorders
  • Other Therapeutic Areas

 

  • Size of manufacturer
  • Small
  • Mid-sized
  • Large

 

  • Key Geographical Region 
  • North America
  • Europe
  • Asia-Pacific and Rest of the World 

 

The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030. report features the following companies, which we identified to be key players in this domain:

  • Agilent Technologies
  • Ajinomoto Bio-Pharma Services
  • BioSpring
  • CordenPharma
  • Integrated DNA Technologies
  • Kaneka Eurogentec
  • LGC Biosearch Technologies
  • Microsynth
  • Nitto Denko Avecia
  • Sigma Aldrich
  • Thermo Fisher Scientific
  • Trilink Biotechnologies

 

Table of Contents

 

  1. 1. Preface

    Executive Summary

  2. Introduction

  3. Market Landscape: Oligonucleotide Manufacturers (Research and Diagnostic Applications)

  4. Market Landscape: Oligonucleotide Manufacturers (Therapeutic Applications)

  5. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Research and Diagnostic Applications)

  6. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Therapeutic Applications)

  7. Company Profiles: Oligonucleotide Manufacturers (Research and Diagnostic Applications)

  8. Company Profiles: Oligonucleotide Manufacturers (Therapeutic Applications)

  9. Partnerships and Collaborations

  10. Recent Expansions

  11. Clinical Trial Analysis

 

  1. Capacity Analysis

 

  1. Demand Analysis

  2. Market Sizing and Opportunity Analysis

 

  1. Swot Analysis

  2. Survey Analysis

 

  1. Executive Insights

 

  1. Concluding Remarks

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

Share:

Keywords: roots analysis,research,pharma,biotech,analysis,market research,industry reports,business report,global

Comments

Other related blogs

Diet supplement is planned to help you

By : Lenofit Keto

Lenofit Keto Diet supplement is planned to help you with your weight decline. It could help with you..


One assessment even communicates

By : Lenofit Keto

Lenofit Keto One assessment even communicates that using the eating routine can help assimilation an..


The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis

By : Roots Analysis

Advances in the field of disease diagnostics have led to a substantial increase in the development o..


The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis2

By : Roots Analysis

The increasing medical diagnostic imaging burden has compelled industry players to develop advanced ..